Encouraging Progress in Bringing Pharmaceutical Manufacturing Back From China to the U.S.

05/14/2025 Robert F. Kennedy Jr., U.S. Secretary of Health and Human Services : The progress in bringing pharmaceutical production back from China to the United States is truly encouraging. Some of this progress is a direct result of President Trump's tariffs. For example, Eli Lilly is building what will be the largest API manufacturing facility in the United States, which could help us regain dominance in this market from China.
#RFKJr. #EliLilly #API #TrumpTariffs
05/14/2025 美国卫生与公众服务部部长小罗伯特·肯尼迪：将药品生产从中国迁回美国的进展非常令人鼓舞。其中一些进展是川普总统加征关税的直接结果。例如，礼来公司正在美国新建一个最大的活性药物成分(API)生产工厂，这将有助于我们从中国手中重新夺回这一市场的主导地位。
#小罗伯特·肯尼迪 #礼来公司 #活性药物成分 #川普关税